An update on current and future treatment options for chondrosarcoma
Introduction: Human chondrosarcomas (CS; a malignant cartilage-forming bone tumor)
respond poorly to chemotherapy and radiation treatment, resulting in high morbidity and …
respond poorly to chemotherapy and radiation treatment, resulting in high morbidity and …
The clinical management of chondrosarcoma
Opinion statement Chondrosarcomas (CHS) represent a heterogeneous group of disorders
ranging from indolent, low-grade tumors to aggressive, high-grade forms. Surgical resection …
ranging from indolent, low-grade tumors to aggressive, high-grade forms. Surgical resection …
Chondrosarcoma-from molecular pathology to novel therapies
AE Zając, S Kopeć, B Szostakowski, MJ Spałek… - Cancers, 2021 - mdpi.com
Simple Summary Chondrosarcoma (CHS) belongs to a broad group of sarcomas and is the
second most frequent malignant bone tumor. Due to its resistance to chemo-and …
second most frequent malignant bone tumor. Due to its resistance to chemo-and …
Non-conventional treatments for conventional chondrosarcoma
Chondrosarcomas are the most common malignant tumors of the cartilage, are seen
predominantly in adults, and have varied clinical behavior. The majority of them affect the …
predominantly in adults, and have varied clinical behavior. The majority of them affect the …
[HTML][HTML] Advanced chondrosarcomas: role of chemotherapy and survival
A Italiano, O Mir, A Cioffi, E Palmerini… - Annals of oncology, 2013 - Elsevier
Background There are limited data about the role of chemotherapy in patients with
advanced chondrosarcomas. Methods The medical charts of 180 patients with advanced …
advanced chondrosarcomas. Methods The medical charts of 180 patients with advanced …
The clinical approach towards chondrosarcoma
Abstract Learning Objectives After completing this course, the reader will be able to: Classify
the chondrosarcoma subtypes. Engage in the diagnostic process of chondrosarcoma …
the chondrosarcoma subtypes. Engage in the diagnostic process of chondrosarcoma …
Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013
AM van Maldegem, JVMG Bovée… - Clinical sarcoma …, 2014 - Springer
Background The majority of patients with chondrosarcoma of bone have an excellent overall
survival after local therapy. However, in case of unresectable locally advanced or metastatic …
survival after local therapy. However, in case of unresectable locally advanced or metastatic …
Outcome of first‐line systemic treatment for unresectable conventional, dedifferentiated, mesenchymal, and clear cell chondrosarcoma
A van Maldegem, AP Conley, P Rutkowski… - The …, 2019 - academic.oup.com
Background Chondrosarcoma is a heterogeneous group of primary bone sarcoma with an
excellent overall survival after local therapy. However, the small percentage of patients who …
excellent overall survival after local therapy. However, the small percentage of patients who …
Systemic therapy for chondrosarcoma
A Rock, S Ali, WA Chow - Current Treatment Options in Oncology, 2022 - Springer
Opinion statement Clinical trial enrollment should be actively encouraged in all patients
diagnosed with advanced, surgically unresectable chondrosarcoma (CS) due to the lack of …
diagnosed with advanced, surgically unresectable chondrosarcoma (CS) due to the lack of …
Therapeutic targets and emerging treatments in advanced chondrosarcoma
S Miwa, N Yamamoto, K Hayashi, A Takeuchi… - International Journal of …, 2022 - mdpi.com
Simple Summary Chondrosarcomas develop chemoresistance to standard anticancer
drugs, making it difficult to control unresectable or metastatic chondrosarcomas. To improve …
drugs, making it difficult to control unresectable or metastatic chondrosarcomas. To improve …